scholarly journals A Patient with a Sudden Onset of Oral Pigmentation

2020 ◽  
pp. 60-65
Author(s):  
Jack Botros ◽  
Firoozeh Samim

Addison's disease or primary adrenal insufficiency (hypoadrenocorticism) is an endocrine disease characterized by a deficiency in the production of the adrenal cortex hormones, particularly cortisol and aldosterone. Patients affected by Addison's disease develop anorexia, weight loss, hypoglycemia, fatigue, nausea, vomiting, skin, and mucosal pigmentation. Skin pigmentation is considered a commonly encountered manifestation of the disease; however, oral mucous membrane pigmentation is rarely noticed early enough for diagnosis. This case report demonstrates a case where oral pigmentation was an early diagnostic sign of Addison's disease.

1987 ◽  
Vol 38 (4) ◽  
pp. 435-437 ◽  
Author(s):  
Katsuyoshi Mineura ◽  
Tsuneo Goto ◽  
Motohiro Yoneya ◽  
Masayoshi Kowada ◽  
Yoshihara Tamakawa ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-5 ◽  
Author(s):  
Viktoriya Mozolevska ◽  
Anna Schwartz ◽  
David Cheung ◽  
Bilal Shaikh ◽  
Kapil M. Bhagirath ◽  
...  

Addison’s disease is often accompanied by a number of cardiovascular manifestations. We report the case of a 30-year-old man who presented with a new onset dilated cardiomyopathy due to Addison’s disease. The clinical presentation, treatment, and outcomes of this rare hormone mediated cardiac disorder are reviewed.


1990 ◽  
Vol 76 (6) ◽  
pp. 611-613 ◽  
Author(s):  
Matilde Navarro ◽  
Enriqueta Felip ◽  
Luis Garcia ◽  
Joaquin Bellmunt ◽  
Laura Jolis ◽  
...  

2015 ◽  
Vol 55 ◽  
pp. 1-7 ◽  
Author(s):  
Katharina Schultebraucks ◽  
Katja Wingenfeld ◽  
Jana Heimes ◽  
Marcus Quinkler ◽  
Christian Otte

1980 ◽  
Vol 95 (1) ◽  
pp. 71-74 ◽  
Author(s):  
A. Jara-Albarrán ◽  
J. Bayort ◽  
A. Caballero ◽  
R. Eusebio ◽  
P. García-Peris ◽  
...  

Abstract. Somatostatin (250 μg as a bolus iv and 250 μg as a I h infusion) was administered to 6 patients with primary adrenal insufficiency (Addison's disease). The fall in plasma ACTH during the infusion period ranged between 0–30% with a mean reduction of 11.2 ± 11.6%. These findings suggest that with the method employed, somatostatin is not an inhibitor of ACTH secretion in a condition in which glucocorticoids are lacking.


Sign in / Sign up

Export Citation Format

Share Document